AirXpanders Inc and Radformation Inc have entered into a co-marketing agreement to introduce Radformation’s EZFluence software to Radiation Oncology departments that are treating AeroForm patients in the US.
The co-marketing agreement enables AirXpanders sales personnel to introduce the EZFluence software to radiation oncology departments who are treating patients with the AeroForm Tissue Expander System.
This collaboration is expected to improve acceptance of the AeroForm Expander by significantly improving the workflow required to develop radiation treatment plans. By collaborating on the introduction of the EZFluence software, both organizations expect Radiation Oncology departments to benefit from the intelligent automation of radiation therapy treatment planning for breast reconstruction patients, a media release from AirXpanders Inc explains.
“We have been very impressed with the EZfluence software,” says Mark Payne, VP, Research and Development of AirXpanders, in the release.
“The intelligent automation this software provides for opposed tangent fields, using both field-in-field and E-comp techniques, is impressive in its thoroughness and ability to effectively develop a radiation treatment plan in minutes from a patient CT scan. The plans developed by this software exhibit significantly improved homogeneity compared to conventionally determined iterative plans.
“We expect radiation oncology departments will appreciate the dramatic reduction in the time needed to develop a treatment plan for patients with an AeroForm, and an overall increase in their productivity for all their breast radiation treatment plans,” Payne adds.
“AirXpanders’ goal is to make the patient more comfortable during a difficult time in their lives while maintaining quality treatment. We support this goal and look forward to working with clinics on generating optimal radiation treatment plans for patients,” comments Elisabeth van Wie, medical physicist and chief business officer of Radformation, the release continues.
[Source(s): AirXPanders Inc, PR Newswire]